2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Eylea: new trials by email Literature Review of Eylea trials Research Report on Eylea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 4D-150 in Patients With Diabetic Macular Edema 4D-150 IVT, Aflibercept IVT - Diabetic Macular Edema, Diabetic Retinopathy | Phase 2 | Active not recruiting | 4D Molecular Therapeutics | 72 | 2023-08-09 | 2026-08-21 |
| The Sahlgrenska Anti-VEGF Study Bevacizumab Injection, Aflibercept Injection - Neovascular Age-related Macular Degeneration | Phase 2 | Active not recruiting | Vastra Gotaland Region | 402 | 2020-09-03 | 2025-11-21 |
4D Molecular Therapeutics (1) · Vastra Gotaland Region (1)
Puerto Rico (1) · Sweden (1) · United States (1)
Julie Clark, MD (1) · Madeleine Zetterberg, MD, PhD (1)
2018 (1)